Vancouver – November 03, 2026 -- The International Society for Cell & Gene Therapy (ISCT) is renaming its Institute of Training & Development the ISCT Academy of Training & Development, three years after the program launched in 2023.

ISCT CEO Queenie Jang said the program has outgrown the institute label and that the new name reflects its scale and global reach.

ISCT earned ANSI accreditation for workforce training in 2024

In 2024, ISCT became the first cell and gene therapy (CGT) organization accredited by the ANSI National Accreditation Board for workforce development and training. The accreditation confirms that its programs meet internationally recognized standards. ISCT President Daniel J. Weiss called it a defining milestone reached in a relatively short period.

Academy delivers programs across North America, Europe and Asia

Global and regional advisory boards and planning faculties guide the Academy. Under their direction, ISCT has developed and delivered programs in three regions, tailoring content to regional needs while keeping it globally applicable.

Clinical Pillar adds fellowship program at University of Pennsylvania

The ISCT Clinical Pillar expands specialized training for clinicians. Its inaugural CGT Clinical Applications Program for Fellows took place at the University of Pennsylvania in October 2026. Clinical leaders and faculty took part in an immersive course on the clinical development and application of CGT.

ISCT Chief Medical Officer Jaap Jan Boelens said the program aims to prepare clinicians who will deliver advanced therapies in regional centers as well as academic ones.

The Academy plans to expand access to accredited education and professional development for the global CGT workforce.